These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31877074)

  • 21. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
    Stitzer ML
    Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877
    [No Abstract]   [Full Text] [Related]  

  • 23. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.
    ;
    Obstet Gynecol; 2012 May; 119(5):1070-6. PubMed ID: 22525931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating opioid use disorders during pregnancy: historical, current, and future directions.
    Jones HE
    Subst Abus; 2013; 34(2):89-91. PubMed ID: 23577898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid Use Disorder in Pregnancy.
    Roper V; Cox KJ
    J Midwifery Womens Health; 2017 May; 62(3):329-340. PubMed ID: 28561914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
    Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
    Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
    J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
    Pan A; Zakowski M
    Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Practical Approach to Neonatal Opiate Withdrawal Syndrome.
    Devlin LA; Davis JM
    Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.
    Patel P; Abdel-Latif ME; Hazelton B; Wodak A; Chen J; Emsley F; Feller JM; Lui K; Oei JL
    J Paediatr Child Health; 2013 Sep; 49(9):746-53. PubMed ID: 23745982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing opioid dependence in pregnancy -- a general practice perspective.
    Arunogiri S; Foo L; Frei M; Lubman DI
    Aust Fam Physician; 2013 Oct; 42(10):713-6. PubMed ID: 24130973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
    Nguyen L; Lander LR; O'Grady KE; Marshalek PJ; Schmidt A; Kelly AK; Jones HE
    Am J Addict; 2018 Mar; 27(2):92-96. PubMed ID: 29473258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas.
    Meyer M; Phillips J
    Prev Med; 2015 Nov; 80():18-22. PubMed ID: 26212632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid addiction in pregnancy.
    Shainker SA; Saia K; Lee-Parritz A
    Obstet Gynecol Surv; 2012 Dec; 67(12):817-25. PubMed ID: 23233054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
    Clark N; Verster A
    Addiction; 2013 Feb; 108(2):253-5. PubMed ID: 23331880
    [No Abstract]   [Full Text] [Related]  

  • 40. Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
    Wong J; Saver B; Scanlan JM; Gianutsos LP; Bhakta Y; Walsh J; Plawman A; Sapienza D; Rudolf V
    J Addict Med; 2018; 12(6):435-441. PubMed ID: 29905586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.